Trial · NCT02837198
Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)
NCT02837198, Phase 2, Completed, Fuji Yakuhin Co., Ltd.
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types). Trials, record NCT02837198. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02837198
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)
- NCT number
- NCT02837198
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 24 participants, actual
- Lead sponsor
- Fuji Yakuhin Co., Ltd.
- Conditions
- Hyperuricemia
- Interventions
- FYU-981, Topiroxostat
- First posted
- 2016-07-19
- Last updated
- 2018-08-21
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pharmacodynamics (Amount of uric acid excreted in urine) | 1-, 2-, 3-, 4-, 5-, 6-,7-,8- and 9-day | |
| Primary | Pharmacodynamics (Renal clearance of uric acid) | 1-, 4- and 7-day | |
| Primary | Pharmacodynamics (Fractional uric acid excretion) | 4- and 7-day | |
| Primary | Pharmacodynamics (Maximum delta effective uric acid concentration) | 1-, 2-, 3-, 4-, 5-, 6- and 7-day | |
| Primary | Pharmacodynamics (Delta area under the serum uric acid concentration-time curve) | 1-, 4- and 7-day | |
| Secondary | Pharmacokinetics (Cmax: Maximum plasma concentration) | 1-, and 7-day | |
| Secondary | Pharmacokinetics (Cmin: Minimum plasma concentration) | 1-, 2-, 3-, 4-, 5-, 6- and 7-day | |
| Secondary | Pharmacokinetics (Tmax: Time to reach the peak plasma concentration) | 1-, and 7-day | |
| Secondary | Pharmacokinetics (T1/2: Elimination half-life of plasma concentration) | 1-, and 7-day | |
| Secondary | Pharmacokinetics (AUC: Area under the plasma concentration-time curve) | 1-, and 7-day |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 31734820 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02837198
GET https://conductscience.org/api/trials/v1/NCT02837198/registered